62 results on '"Foulkes, W. D."'
Search Results
2. Cloning and molecular characterization of monoclonal antibody-defined ovarian tumour antigens
3. Survey of primary care physicians’ views about breast and ovarian cancer screening for true BRCA1/2 non-carriers
4. No Evidence of Excessive Cancer Screening in Female Noncarriers from BRCA1/2 Mutation–Positive Families
5. Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
6. Oncogenic role of PDK4 in human colon cancer cells
7. Breast cancer in systemic lupus
8. Functional characterization of multiple DICER1 mutations in an adolescent
9. ATYPICAL TERATOID RHABDOID TUMOUR
10. CARD9 Deficiency and Spontaneous Central Nervous System Candidiasis: Complete Clinical Remission With GM-CSF Therapy
11. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
12. Serum levels of mature microRNAs in DICER1-mutated pleuropulmonary blastoma
13. Erratum: DICER1 hotspot mutations in non-epithelial gonadal tumours
14. DICER1 hotspot mutations in non-epithelial gonadal tumours
15. The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial
16. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
17. Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
18. Genetic architecture of prostate cancer in the Ashkenazi Jewish population
19. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis
20. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
21. Germline PALB2 mutation analysis in breast-pancreas cancer families
22. Neonatal Gardner Fibroma: A Sentinel Presentation of Severe Familial Adenomatous Polyposis
23. Germline DICER1 mutations and familial cystic nephroma
24. Clinical Implications of Next-Generation Sequencing for Cancer Medicine
25. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer
26. Transforming growth factor‐beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes
27. Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness
28. Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
29. Re: Estrogen Receptor Status of Primary Breast Cancer Is Predictive of Estrogen Receptor Status of Contralateral Breast Cancer
30. RESPONSE: Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
31. BRCA1 functions as a breast stem cell regulator
32. Germline truncating mutations in both MSH2 and BRCA2 in a single kindred
33. Re: Gynecologic Surgeries and Risk of Ovarian Cancer in Women with BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study
34. Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
35. Re: Potential for Bias in Studies on Efficacy of Prophylactic Surgery for BRCA1 and BRCA2 Mutation Carriers
36. Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
37. Re: Italian Randomized Trial Among Women With Hysterectomy: Tamoxifen and Hormone-Dependent Breast Cancer in High-Risk Women
38. Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status
39. Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study
40. Is there a correlation between the structure of hair and breast cancer or BRCA1/2 mutations?
41. Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
42. A Comprehensive Analysis ofMNG1,TCO1,fPTC,PTEN,TSHR, and TRKA in Familial Nonmedullary Thyroid Cancer: Confirmation of Linkage to TCO1
43. Re: Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients
44. Penetrance of Mutations in the Familial Wilms Tumor Gene FWT1
45. No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck
46. The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer
47. A missense mutation in both hMSH2 andAPC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening
48. Loss of heterozygosity of methylenetetrahydrofolate reductase in colon carcinomas.
49. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours
50. Fortnightly review: Hereditary ovarian carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.